Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
Scope of the Report:
This report focuses on the Bipolar Disorder Therapeutic in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.
The Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the major factors responsible for the market's growth in the region are the high incidence of bipolar disorder symptoms in the US, the growing number of pipeline products, the rising awareness about these disorders in the region, and the growing prevalence of pediatric bipolar disorders.
The worldwide market for Bipolar Disorder Therapeutic is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antipsychotics
Anticonvulsants
Mood Stabilizers
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
There are 15 Chapters to deeply display the global Bipolar Disorder Therapeutic market.
Chapter 1, to describe Bipolar Disorder Therapeutic Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bipolar Disorder Therapeutic, with sales, revenue, and price of Bipolar Disorder Therapeutic, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bipolar Disorder Therapeutic, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bipolar Disorder Therapeutic market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bipolar Disorder Therapeutic sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bipolar Disorder Therapeutic Introduction
1.2 Market Analysis by Type
1.2.1 Antipsychotics
1.2.2 Anticonvulsants
1.2.3 Mood Stabilizers
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Bipolar Disorder Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Bipolar Disorder Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Bipolar Disorder Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan
2.4.1 Business Overview
2.4.2 Bipolar Disorder Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas Pharma
2.5.1 Business Overview
2.5.2 Bipolar Disorder Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas Pharma Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Bipolar Disorder Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Janssen Pharmaceuticals
2.7.1 Business Overview
2.7.2 Bipolar Disorder Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bipolar Disorder Therapeutic Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Bipolar Disorder Therapeutic Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bipolar Disorder Therapeutic Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Bipolar Disorder Therapeutic Manufacturer Market Share in 2017
3.3.2 Top 6 Bipolar Disorder Therapeutic Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Bipolar Disorder Therapeutic Market Analysis by Regions
4.1 Global Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Regions
4.1.1 Global Bipolar Disorder Therapeutic Sales and Market Share by Regions (2013-2018)
4.1.2 Global Bipolar Disorder Therapeutic Revenue and Market Share by Regions (2013-2018)
4.2 North America Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
4.3 Europe Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
4.5 South America Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
5 North America Bipolar Disorder Therapeutic by Countries
5.1 North America Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Countries
5.1.1 North America Bipolar Disorder Therapeutic Sales and Market Share by Countries (2013-2018)
5.1.2 North America Bipolar Disorder Therapeutic Revenue and Market Share by Countries (2013-2018)
5.2 United States Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
5.3 Canada Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
5.4 Mexico Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
6 Europe Bipolar Disorder Therapeutic by Countries
6.1 Europe Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Countries
6.1.1 Europe Bipolar Disorder Therapeutic Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Bipolar Disorder Therapeutic Revenue and Market Share by Countries (2013-2018)
6.2 Germany Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
6.3 UK Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
6.4 France Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
6.5 Russia Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
6.6 Italy Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
7 Asia-Pacific Bipolar Disorder Therapeutic by Countries
7.1 Asia-Pacific Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bipolar Disorder Therapeutic Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Bipolar Disorder Therapeutic Revenue and Market Share by Countries (2013-2018)
7.2 China Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
7.3 Japan Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
7.4 Korea Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
7.5 India Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
8 South America Bipolar Disorder Therapeutic by Countries
8.1 South America Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Countries
8.1.1 South America Bipolar Disorder Therapeutic Sales and Market Share by Countries (2013-2018)
8.1.2 South America Bipolar Disorder Therapeutic Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
8.3 Argentina Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
8.4 Colombia Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
9 Middle East and Africa Bipolar Disorder Therapeutic by Countries
9.1 Middle East and Africa Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bipolar Disorder Therapeutic Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Bipolar Disorder Therapeutic Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
9.3 UAE Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
9.4 Egypt Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
9.5 Nigeria Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
9.6 South Africa Bipolar Disorder Therapeutic Sales and Growth Rate (2013-2018)
10 Global Bipolar Disorder Therapeutic Market Segment by Type
10.1 Global Bipolar Disorder Therapeutic Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bipolar Disorder Therapeutic Sales and Market Share by Type (2013-2018)
10.1.2 Global Bipolar Disorder Therapeutic Revenue and Market Share by Type (2013-2018)
10.2 Antipsychotics Sales Growth and Price
10.2.1 Global Antipsychotics Sales Growth (2013-2018)
10.2.2 Global Antipsychotics Price (2013-2018)
10.3 Anticonvulsants Sales Growth and Price
10.3.1 Global Anticonvulsants Sales Growth (2013-2018)
10.3.2 Global Anticonvulsants Price (2013-2018)
10.4 Mood Stabilizers Sales Growth and Price
10.4.1 Global Mood Stabilizers Sales Growth (2013-2018)
10.4.2 Global Mood Stabilizers Price (2013-2018)
11 Global Bipolar Disorder Therapeutic Market Segment by Application
11.1 Global Bipolar Disorder Therapeutic Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 Bipolar Disorder Therapeutic Market Forecast (2018-2023)
12.1 Global Bipolar Disorder Therapeutic Sales, Revenue and Growth Rate (2018-2023)
12.2 Bipolar Disorder Therapeutic Market Forecast by Regions (2018-2023)
12.2.1 North America Bipolar Disorder Therapeutic Market Forecast (2018-2023)
12.2.2 Europe Bipolar Disorder Therapeutic Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bipolar Disorder Therapeutic Market Forecast (2018-2023)
12.2.4 South America Bipolar Disorder Therapeutic Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bipolar Disorder Therapeutic Market Forecast (2018-2023)
12.3 Bipolar Disorder Therapeutic Market Forecast by Type (2018-2023)
12.3.1 Global Bipolar Disorder Therapeutic Sales Forecast by Type (2018-2023)
12.3.2 Global Bipolar Disorder Therapeutic Market Share Forecast by Type (2018-2023)
12.4 Bipolar Disorder Therapeutic Market Forecast by Application (2018-2023)
12.4.1 Global Bipolar Disorder Therapeutic Sales Forecast by Application (2018-2023)
12.4.2 Global Bipolar Disorder Therapeutic Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bipolar Disorder Therapeutic Picture
Table Product Specifications of Bipolar Disorder Therapeutic
Figure Global Sales Market Share of Bipolar Disorder Therapeutic by